Neurocrine Bioscienc
(NBIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 794,900 | 687,500 | 572,600 | 627,700 | 622,100 |
| Cost of Goods | 14,000 | 11,300 | 9,200 | 9,300 | 8,000 |
| Gross Profit | 780,900 | 676,200 | 563,400 | 618,400 | 614,100 |
| Operating Expenses | 541,900 | 530,900 | 540,000 | 476,700 | 430,300 |
| Operating Income | 239,000 | 145,600 | 23,600 | 142,000 | 183,800 |
| Other Income | 52,800 | 13,900 | -8,900 | 20,600 | 6,500 |
| Pre-tax Income | 291,800 | 159,500 | 14,700 | 162,600 | 190,300 |
| Income Tax | 82,300 | 52,000 | 6,800 | 59,500 | 60,500 |
| Net Income Continuous | 209,500 | 107,500 | 7,900 | 103,100 | 129,800 |
| Net Income | $209,500 | $107,500 | $7,900 | $103,100 | $129,800 |
| EPS Basic Total Ops | 2.11 | 1.09 | 0.08 | 1.05 | 1.28 |
| EPS Basic Continuous Ops | 2.11 | 1.09 | 0.08 | 1.04 | 1.28 |
| EPS Diluted Total Ops | 2.04 | 1.06 | 0.08 | 1.00 | 1.24 |
| EPS Diluted Continuous Ops | 2.04 | 1.06 | 0.08 | 1.00 | 1.24 |
| EPS Diluted Before Non-Recurring Items | 2.04 | 1.06 | 0.08 | 1.00 | 1.24 |
| EBITDA(a) | $246,700 | $152,900 | $31,200 | $122,900 | $190,300 |